Humana Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Humana şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

Geri Alım Getirisi

Toplam Hissedar Getirisi	0%
Gelecekteki Temettü Verimi	4.4%
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	€0.700
Ödeme oranı	0%

Son temettü ve geri alım güncellemeleri

Recent updates

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: 47H şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: 47H şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Humana Piyasaya Karşı Temettü Getirisi

47H temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (47H)	0%
Pazarın Alt %25'i (DE)	1.7%
Pazarın En İyi %25'i (DE)	4.8%
Sektör Ortalaması (Healthcare)	2.7%
Analist tahmini (47H) (3 yıla kadar)	4.4%

Önemli Temettü: 47H şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, 47H şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: 47H German piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: 47H herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Humana Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Humana AB (Publ) Proposes No Dividend for the Financial Year 2020

Recent updates

Third quarter 2024 earnings released: EPS: kr1.81 (vs kr1.72 in 3Q 2023)

Humana AB (publ), Annual General Meeting, May 06, 2025

Humana AB Appoints Christoffer Herou as New CFO, Effective September 2, 2024

Second quarter 2024 earnings released: EPS: kr0.02 (vs kr0.75 in 2Q 2023)

New minor risk - Shareholder dilution

Fredrik Larsson, CFO of the Humana Group, to Leave His Position

Humana AB (Publ) Announces CEO Changes

Full year 2023 earnings released: EPS: kr3.68 (vs kr4.38 in FY 2022)

Humana AB (Publ) Announces Nomination Committee for the Annual General Meeting 2024

Humana Announces Board Changes, Effective May 1, 2024

New minor risk - Share price stability

Full year 2023 earnings released: EPS: kr3.68 (vs kr4.38 in FY 2022)

Humana Announces the Resignation of Johanna Rastad as President

Humana AB (publ) to Report Fiscal Year 2023 Results on Apr 03, 2024

Third quarter 2023 earnings released: EPS: kr1.72 (vs kr2.18 in 3Q 2022)

Humana AB (publ), Annual General Meeting, May 07, 2024

Humana AB (publ) to Report Q4, 2023 Results on Feb 08, 2024

Second quarter 2023 earnings released: EPS: kr0.75 (vs kr0.38 in 2Q 2022)

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 39%

Investor sentiment improves as stock rises 15%

Humana AB (publ) Announces Board Appointments

Investor sentiment improves as stock rises 19%

Full year 2022 earnings released: EPS: kr4.38 (vs kr5.67 in FY 2021)

Investor sentiment improves as stock rises 16%

Full year 2022 earnings released: EPS: kr4.37 (vs kr5.67 in FY 2021)

Sören Mellstig Not Stands for the Re-Election to the Board of Humana AB (Publ)

Humana AB (publ) to Report Fiscal Year 2022 Results on Apr 03, 2023

Investor sentiment deteriorates as stock falls 49%

Humana AB (publ) to Report Nine Months, 2023 Results on Nov 09, 2023

Humana AB (Publ) Announces Management Changes

Third quarter 2022 earnings released: EPS: kr2.18 (vs kr2.54 in 3Q 2021)

Third quarter 2022 earnings released: EPS: kr2.18 (vs kr2.54 in 3Q 2021)

Humana AB (publ) to Report Q1, 2023 Results on May 04, 2023

Sön Mellllstig, Chairman of the Board of Humana Ab, Is Not Available for Re-Election at the 2023 Annual General Meeting

Investor sentiment deteriorated over the past week

Humana AB Announces Nomination Committee for 2023 AGM

Second quarter 2022 earnings released: EPS: kr0.38 (vs kr1.19 in 2Q 2021)

Independent Chairman of the Board recently bought €3.5m worth of stock

Noora Jayasekara Leaves Humana Member of Group Management

Humana AB (publ) (OM:HUM) acquired Vintergatan AB.

Humana AB (publ) (OM:HUM) completed the acquistion of Assistans For Dig I Sverige Ab.

Humana AB (publ) (OM:HUM) agreed to acquire Assistans For Dig I Sverige Ab for approximately SEK151 million.

First quarter 2022 earnings released: EPS: kr0.60 (vs kr1.28 in 1Q 2021)

Full year 2021 earnings released

Humana AB (publ) to Report Q3, 2022 Results on Nov 10, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Now 21% undervalued after recent price drop

Humana AB (publ) (OM:HUM) acquired Kalliola Oy - Uudet Setlementtiratkaisut.

Third quarter 2021 earnings released: EPS kr2.54 (vs kr2.05 in 3Q 2020)

Director of Marketing & Communication Helena Pharmanson has left the company

Director of Human Resources Anna Skablova has left the company

Second quarter 2021 earnings released: EPS kr1.18 (vs kr0.94 in 2Q 2020)

Independent Director has left the company

Humana AB (Publ) Proposes No Dividend for the Financial Year 2020

First quarter 2021 earnings released: EPS kr1.28 (vs kr1.00 in 1Q 2020)

Full year 2020 earnings released

Full year 2020 earnings released: EPS kr4.94 (vs kr3.54 in FY 2019)

Revenue beats expectations

New 90-day high: €6.29

Humana AB (publ) to Report Fiscal Year 2020 Results on Apr 01, 2021

Humana AB (publ) (OM:HUM) acquired J-son Företagspartner AB from Anna Maxe and David Jansson and family.

Humana AB (publ) Announces Nomination Committee for 2021 AGM

New 90-day high: €6.07

New 90-day high: €5.91

Third quarter 2020 earnings released: EPS kr2.05

Revenue misses expectations

Humana AB (publ) to Report Q3, 2021 Results on Nov 11, 2021

Humana AB (publ) to Report First Half, 2021 Results on Aug 20, 2021

Humana AB (publ) (OM:HUM) acquired RO Omsorg Assistans AB.

New 90-day high: €5.90

Earnings released

New 90-day high - €5.14

Ödemelerde İstikrar ve Büyüme